Literature DB >> 20473744

Research on the mechanism of Zuogui Pill and Yougui Pill in promoting axonal regeneration in model rats of autoimmune encephalomyelitis.

Lei Wang1, Hui Zhao, Yong-ping Fan, Hai-yang Gong, Ming Li, Fang Qi, Yan Liu.   

Abstract

OBJECTIVE: To study the molecular mechanism of Zuogui Pill (ZGP) and Yougui Pill (YGP) on axonal regeneration in rats with experimental autoimmune encephalomyelitis (EAE).
METHODS: EAE rat model was established by bilateral rear pedes subcutaneous injection of antigen made by mixing myelin basic protein (MBP) and complete Freud's adjuvant (CFA) in the volume ratio of 1:1. The pathological changes of axonal injury and regeneration in the brain and the spinal cord were observed on the 14th (the acute stage) and the 28th day (the remission stage) after modeling, with hematoxylin-eosin (HE) staining, silver stain, and immunohistochemical staining. The rats treated with prednisone acetate were taken as controls.
RESULTS: Observation under the light microscope with HE staining showed a sleeve-like change in rats' cerebrospinal parenchyma with inflammatory cell infiltration around the small vessels and neuronic denaturation, while silver staining showed excessive tumefaction and abscission of axon, and immunohistochemical analysis showed decreasing of nerve growth factor (NGF) expression at the acute stage of EAE, which was even more remarkable at the remission stage, showing significant difference as compared with the normal control (P<0.05). And the expressions of Nogo A, an axon growth inhibitor, and its receptor (Nogo-66 receptor, Ng R) were significantly higher than those in the normal control at the acute stage (P<0.01). However, after the intervention of ZGP and YGP, the pathological changes and axon damage in rats' brain and spinal cord were much more alleviated, and the NGF expression was significantly higher than that in the model group at the acute stage (P<0.05). The expression of NGF was even stronger during the remission stage, and a better effect was shown by YGP. As for Nogo A and Ng R expressions, they were significantly lower than those in the model group at the acute stage (P<0.05), but a better effect was shown by ZGP.
CONCLUSIONS: ZGP and YGP can prevent axonal injury and promote the axonal regeneration in rats of EAE, and the possible mechanism is to increase the expression of NGF and reduce the expression of Nogo A and its receptor. However, some differences are observed between the two Chinese preparations in their acting times and points, which provides a certain basis for revealing the modern connotation of the Chinese medicine theory on tonifying Shen ()-yin and Shen-yang.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20473744     DOI: 10.1007/s11655-010-0167-z

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  5 in total

1.  P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp.

Authors:  Kevin C Wang; Jieun A Kim; Rajeev Sivasankaran; Rosalind Segal; Zhigang He
Journal:  Nature       Date:  2002-10-20       Impact factor: 49.962

2.  Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1.

Authors:  M S Chen; A B Huber; M E van der Haar; M Frank; L Schnell; A A Spillmann; F Christ; M E Schwab
Journal:  Nature       Date:  2000-01-27       Impact factor: 49.962

3.  Nerve growth factor prevents demyelination, cell death and progression of the disease in experimental allergic encephalomyelitis.

Authors:  Azita Parvaneh Tafreshi
Journal:  Iran J Allergy Asthma Immunol       Date:  2006-12       Impact factor: 1.464

4.  Nogo-A and nogo receptor expression in demyelinating lesions of multiple sclerosis.

Authors:  Jun-Ichi Satoh; Hiroyuki Onoue; Kunimasa Arima; Takashi Yamamura
Journal:  J Neuropathol Exp Neurol       Date:  2005-02       Impact factor: 3.685

5.  A comparative study of experimental autoimmune encephalomyelitis in Lewis and DA rats.

Authors:  J A Stepaniak; K E Gould; D Sun; R H Swanborg
Journal:  J Immunol       Date:  1995-09-01       Impact factor: 5.422

  5 in total
  4 in total

1.  Effect of Bushen Yisui Capsule () on oligodendrocyte lineage genes 1 and 2 in mice with experimental autoimmune encephalomyelitis.

Authors:  Tao Yang; Qi Zheng; Hui Zhao; Qiu-Xia Zhang; Ming Li; Fang Qi; Kang-Ning Li; Ling Fang; Lei Wang; Yong-Ping Fan
Journal:  Chin J Integr Med       Date:  2016-02-26       Impact factor: 1.978

2.  Nogo-A expression dynamically varies after spinal cord injury.

Authors:  Jian-Wei Wang; Jun-Feng Yang; Yong Ma; Zhen Hua; Yang Guo; Xiao-Lin Gu; Ya-Feng Zhang
Journal:  Neural Regen Res       Date:  2015-02       Impact factor: 5.135

3.  Effect of catalpol on remyelination through experimental autoimmune encephalomyelitis acting to promote Olig1 and Olig2 expressions in mice.

Authors:  Tao Yang; Qi Zheng; Su Wang; Ling Fang; Lei Liu; Hui Zhao; Lei Wang; Yongping Fan
Journal:  BMC Complement Altern Med       Date:  2017-05-02       Impact factor: 3.659

4.  Pharmacokinetics of the Yougui pill in experimental autoimmune encephalomyelitis model rats and its pharmacological activity in vitro.

Authors:  Haolong Liu; Feng Qiu; Xinwei Yang; Haiyu Zhao; Baolin Bian; Lei Wang
Journal:  Drug Des Devel Ther       Date:  2019-07-16       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.